Access cutting-edge myocarditis treatment through this clinical trial at a research site in Indianapolis. Study-provided care at no cost to qualified participants.
Access myocarditis specialists in Indianapolis at no cost
This study follows strict safety protocols and ethical guidelines
All study-related myocarditis treatment provided free
The primary aim is to test whether abatacept, as compared to placebo, is associated with a reduction in major adverse cardiac events (MACE) among participants hospitalized with myocarditis secondary to an immune checkpoint inhibitor (ICI). The primary outcome, MACE, is a composite of first occurrence of cardiovascular death, non-fatal sudden cardiac arrest, cardiogenic shock, significant ventricular arrythmias, significant bradyarrythmias, or incident heart failure.
Sponsor: Massachusetts General Hospital
Check if you qualify for this myocarditis clinical trial in Indianapolis, IN
If you're searching for myocarditis treatment options in Indianapolis, IN, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Indianapolis research site is actively enrolling participants for this clinical trial. You'll receive care from experienced myocarditis specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.